Skip to main content
. 2002 Sep;76(18):9035–9045. doi: 10.1128/JVI.76.18.9035-9045.2002

TABLE 1.

Reactivities of human MAbs with V3JR-CSF-FP and V3JR-CSF linear peptides

MAb Half-maximal binding toa:
P value
V3-FP V3 peptide
2182 0.02 ± 0.01 0.14 ± 0.03 0.071
2191 0.04 ± 0.02 0.83 ± 0.09 0.015
2219 0.02 ± 0.01 0.84 ± 0.16 0.036
2412 0.02 ± 0.01 2.21 ± 0.01 0.0001
2442 0.02 ± 0.01 1.40 ± 0.2 0.02
2456 0.03 ± 0.02 2.10 ± 0.4 0.035
447-52Db 0.01 ± 0.01 0.16 ± 0.07 0.17
a

ELISA plates coated with V3-FP and V3 peptide at 59 nM concentration; mean of two experiments (micrograms per milliliter ± standard deviation).

b

Control human anti-V3 MAb selected with V3MN peptide.